Abstract:Fragile X syndrome is an inheritable form of intellectual disability caused by loss of fragile X mental retardation protein (FMRP, encoded by the FMR1 gene). Absence of FMRP caused overexpression of progranulin (PGRN, encoded by GRN), a putative tumour necrosis factor receptor ligand. In the present study, we found that progranulin mRNA and protein were upregulated in the medial prefrontal cortex of Fmr1 knock-out mice. In Fmr1 knock-out mice, elevated progranulin caused insufficient dendritic spine pruning and late-phase long-term potentiation in the medial prefrontal cortex of Fmr1 knock-out mice. Partial progranulin knock-down restored spine morphology and reversed behavioural deficits, including impaired fear memory, hyperactivity, and motor inflexibility in Fmr1 knock-out mice. Progranulin increased levels of phosphorylated glutamate ionotropic receptor GluA1 and nuclear factor kappa B in cultured wild-type neurons. Tumour necrosis factor receptor 2 antibody perfusion blocked the effects of progranulin on GluA1 phosphorylation; this result indicates that tumour necrosis factor receptor 2 is required for progranulin-mediated GluA1 phosphorylation and late-phase long-term potentiation expression. However, high basal level of progranulin in Fmr1 knock-out mice prevented further facilitation of synaptic plasticity by exogenous progranulin. Partial downregulation of progranulin or tumour necrosis factor receptor 2/nuclear factor kappa B signalling restored synaptic plasticity and memory deficits in Fmr1 knock-out mice. These findings suggest that elevated PGRN is linked to cognitive deficits of fragile X syndrome, and the progranulin/tumour necrosis factor receptor 2 signalling pathway may be a putative therapeutic target for improving cognitive deficits in fragile X syndrome.

Structure dissection of human progranulin identifies well-folded granulin/epithelin modules with unique functional activities.

Structure Dissection of Zebrafish Progranulins Identifies a Well-Folded Granulin/epithelin Module Protein with Pro-Cell Survival Activities.

Structure, Function, and Mechanism of Progranulin; the Brain and Beyond

Biological Function Analysis of Monoclonal Antibodies Against Human Granulins in Vitro Using U251 Cells As a Model.

Pathogenic cysteine mutations affect progranulin function and production of mature granulins.

Structures of Human Gastrin-Releasing Peptide Receptors Bound to Antagonist and Agonist for Cancer and Itch Therapy.

Methods to Investigate the Molecular Basis of Progranulin Actions on Brain and Behavior In Vivo Using Knockout Mice

Cloning, expression and cytotoxicity of granulin A, a novel polypeptide contained in human progranulin.

Progranulin in Regulation Mechanism of Glycolipid Metabolism and Renal Disease

Progranulinopathy: A diverse realm of disorders linked to progranulin imbalances

Disease and Region Specificity of Granulin Immunopositivities in Alzheimer Disease and Frontotemporal Lobar Degeneration.

Elevated Progranulin Contributes to Synaptic and Learning Deficit Due to Loss of Fragile X Mental Retardation Protein.

Identification of biological pathways regulated by PGRN and GRN peptide treatments using transcriptome analysis

Losing protein in the brain: the case of progranulin

Progranulin: A promising biomarker and therapeutic target for fibrotic diseases

Progranulin as a therapeutic target in neurodegenerative diseases

Lysosomal functions of progranulin and implications for treatment of frontotemporal dementia

Domain-specific monoclonal antibodies produced against human PGRN.

Granulins rescue inflammation, lysosome dysfunction, lipofuscin, and neuropathology in a mouse model of progranulin deficiency

RESEARCH ARTICLE Progranulin promotes neurite outgrowth and

Progranulin promotes neurite outgrowth and neuronal differentiation by regulating GSK-3β